Xu TT - Search Results

1

Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis.

Qin GW, Xu TT, Lv XW, Jiang SM, Zhang KJ, Xu M, Fu L, Wu Q, Zhou Y. Qin GW, et al. Among authors: xu m, xu tt. Evid Based Complement Alternat Med. 2021 Apr 13;2021:7929165. doi: 10.1155/2021/7929165. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33936245 Free PMC article.

2

Safety and Efficacy of Ginkgo-Damole and Nitroglycerin or Sodium Nitroprusside on Hypertensive Cerebropathies: A Meta-Analysis.

Peng L, Zhao WK, Xu TT, Wu Q, Lu P, Zhu PP, Zheng XM. Peng L, et al. Among authors: xu tt. Evid Based Complement Alternat Med. 2020 Sep 4;2020:5713796. doi: 10.1155/2020/5713796. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32952588 Free PMC article.

3

6-Gingerol Activates PI3K/Akt and Inhibits Apoptosis to Attenuate Myocardial Ischemia/Reperfusion Injury.

Lv X, Xu T, Wu Q, Zhou Y, Huang G, Xu Y, Zhong G. Lv X, et al. Evid Based Complement Alternat Med. 2018 Mar 20;2018:9024034. doi: 10.1155/2018/9024034. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 29743926 Free PMC article.

4

6-Gingerol Protects Heart by Suppressing Myocardial Ischemia/Reperfusion Induced Inflammation via the PI3K/Akt-Dependent Mechanism in Rats.

Xu T, Qin G, Jiang W, Zhao Y, Xu Y, Lv X. Xu T, et al. Evid Based Complement Alternat Med. 2018 Nov 5;2018:6209679. doi: 10.1155/2018/6209679. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30519268 Free PMC article.

5

Corrigendum to "6-Gingerol Protects Heart by Suppressing Myocardial Ischemia/Reperfusion Induced Inflammation via the PI3K/Akt-Dependent Mechanism in Rats".

Xu T, Qin G, Jiang W, Zhao Y, Xu Y, Lv X. Xu T, et al. Evid Based Complement Alternat Med. 2019 Jun 18;2019:7659701. doi: 10.1155/2019/7659701. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31316575 Free PMC article.

6

Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.

Zhao WK, Zhou Y, Xu TT, Wu Q. Zhao WK, et al. Among authors: xu tt. Oxid Med Cell Longev. 2021 Oct 23;2021:9929687. doi: 10.1155/2021/9929687. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34725566 Free PMC article. Review.

7

Overexpression of MiR-29b-3p Inhibits Atrial Remodeling in Rats by Targeting PDGF-B Signaling Pathway.

Lv X, Lu P, Hu Y, Xu T. Lv X, et al. Oxid Med Cell Longev. 2021 Jan 13;2021:3763529. doi: 10.1155/2021/3763529. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33520084 Free PMC article.

8

miR-451-3p alleviates myocardial ischemia/reperfusion injury by inhibiting MAP1LC3B-mediated autophagy.

Lv XW, He ZF, Zhu PP, Qin QY, Han YX, Xu TT. Lv XW, et al. Among authors: xu tt. Inflamm Res. 2021 Dec;70(10-12):1089-1100. doi: 10.1007/s00011-021-01508-4. Epub 2021 Oct 11. Inflamm Res. 2021. PMID: 34633468

9

miR-346 Inhibited Apoptosis Against Myocardial Ischemia-Reperfusion Injury via Targeting Bax in Rats.

Lv X, Lu P, Hu Y, Xu T. Lv X, et al. Drug Des Devel Ther. 2020 Feb 27;14:895-905. doi: 10.2147/DDDT.S245193. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32161448 Free PMC article.

10

[Amelioration of myocardial ischemia/reperfusion injury by leptin pretreatment and ischemic preconditioning in mouse].

Xu TT, Liu SP, Wang XS. Xu TT, et al. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Feb;22(2):105-8. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010. PMID: 20170616 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters